Impact of the crosstalk between the PTEN and PAFR as well as PAFR and EGFR pathways in cancer
The integration between the tumor-suppressive and oncogenic signaling pathways controls various cellular activities of cancer cells, including cell growth and apoptosis. While the activation of oncogenes fuels cancer progression and escape mechanisms, tumor suppressors regulate and counterbalance th...
Saved in:
Main Authors: | Anita Thyagarajan, Zaid Sirhan, Ravi P. Sahu |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2025-01-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100883/100883.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method
by: Zuo Sai-Jie, et al.
Published: (2021-09-01) -
Real‐World Study of EGFR‐TKI Rechallenge With Another TKI After First‐Line Osimertinib Discontinuation in Patients With EGFR‐Mutated Non‐Small Cell Lung Cancer: A Subset Analysis of the Reiwa Study
by: Kei Sonehara, et al.
Published: (2025-01-01) -
HER2 expression and pathway status in male breast cancer patients: results of an integrated analysis among 6,150 patients
by: Boqiang Lyu, et al.
Published: (2025-01-01) -
A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer
by: Danilo Giffoni de Mello Morais Mata, et al.
Published: (2024-12-01) -
The potential of MRI radiomics based on extrapulmonary metastases in predicting EGFR mutations: a systematic review and meta-analysis
by: Linyong Wu, et al.
Published: (2025-01-01)